CDC advisers could reverse newborn hepatitis B vaccine recommendations

NBC NewsWednesday, December 3, 2025 at 10:00:41 AM
NeutralHealth
CDC advisers could reverse newborn hepatitis B vaccine recommendations
  • A group of advisers to the Centers for Disease Control and Prevention (CDC) is set to vote on potentially reversing the long-standing recommendation for newborns to receive a hepatitis B vaccination within 24 hours of birth. This decision could significantly alter vaccination protocols for infants in the United States.
  • The outcome of this vote is crucial as it may impact public health strategies aimed at preventing hepatitis B, a serious liver infection that can lead to chronic disease and liver cancer. The CDC's recommendations often influence healthcare practices nationwide.
  • This potential reversal comes amid ongoing discussions about vaccine safety and efficacy, particularly in light of recent changes in CDC messaging regarding vaccines and autism. The evolving stance on vaccine recommendations reflects broader societal debates about public health policies and parental choice in vaccination.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Continue Readings
Confusion over CDC panel's hepatitis B guidance could disrupt care for babies
NegativeHealth
The CDC advisory panel has recently voted to roll back its recommendation for the hepatitis B vaccine for all newborns, a decision that has sparked confusion and concern among healthcare providers and parents alike. This shift follows a series of contentious meetings characterized by misinformation and debate among panel members.
New CDC Guidelines on Hepatitis B Shot for Infants: What to Know
NeutralHealth
The CDC's advisory panel has reversed a long-standing recommendation that all infants receive the hepatitis B vaccine at birth, a decision that marks a significant shift in vaccination policy. This change follows extensive discussions and reflects evolving perspectives on infant vaccination protocols.